ACH
ACCENDRA HEALTH INC/VA/
NYSE · Healthcare · Medical - Distribution · US
$0.93
−9.86%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- $619.4M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.19
- EPS estimate
- -$0.08
- Revenue actual
- $613.2M
- Revenue estimate
- $628.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -22.3%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $1.50
- PT range
- $1.50 – $1.50
- Analysts
- 2
0 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.08 | -$0.19 | Miss -126.65% | $613.2M |
| May 11, 2026 | -$0.06 | -$0.04 | Beat 33.33% | $627.8M |
| Feb 19, 2026 | $0.22 | $0.21 | Miss -4.55% | $709.0M |
| Oct 30, 2025 | $0.23 | $0.25 | Beat 8.70% | $697.3M |
| May 8, 2025 | $0.20 | $0.23 | Beat 15.00% | $2.6B |
| Feb 28, 2025 | $0.53 | $0.55 | Beat 3.77% | $2.7B |
| Aug 2, 2024 | $0.33 | $0.36 | Beat 10.09% | $2.7B |
| May 3, 2024 | $0.17 | $0.19 | Beat 11.76% | $2.6B |
| Feb 20, 2024 | $0.68 | $0.69 | Beat 1.47% | $2.7B |
| Nov 3, 2023 | $0.35 | $0.44 | Beat 23.94% | $2.6B |
| Aug 4, 2023 | $0.16 | $0.18 | Beat 10.43% | $2.6B |
| May 5, 2023 | -$0.09 | $0.05 | Beat 155.56% | $2.5B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026